Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

K. Bencardino; M. Manzoni; S. Delfanti; A. Riccardi; M. Danova; G. R. Corazza

首页> 外文期刊>Internal and Emergency Medicine >Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

【24h】

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

机译：表皮生长因子受体酪氨酸激酶抑制剂用于非小细胞肺癌的治疗：结果和未解决的问题

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Internal and Emergency Medicine》 |2007年第1期|3-12|共10页
作者
K. Bencardino; M. Manzoni; S. Delfanti; A. Riccardi; M. Danova; G. R. Corazza;
展开▼
作者单位

1st Department of Internal Medicine, Medical Oncology and Gastroenterology, IRCCS San Matteo and University of Pavia, Piazzale C. Golgi 2, I-27100 Pavia, Italy;

1st Department of Internal Medicine, Medical Oncology and Gastroenterology, IRCCS San Matteo and University of Pavia, Piazzale C. Golgi 2, I-27100 Pavia, Italy;

1st Department of Internal Medicine, Medical Oncology and Gastroenterology, IRCCS San Matteo and University of Pavia, Piazzale C. Golgi 2, I-27100 Pavia, Italy;

1st Department of Internal Medicine, Medical Oncology and Gastroenterology, IRCCS San Matteo and University of Pavia, Piazzale C. Golgi 2, I-27100 Pavia, Italy;

1st Department of Internal Medicine, Medical Oncology and Gastroenterology, IRCCS San Matteo and University of Pavia, Piazzale C. Golgi 2, I-27100 Pavia, Italy;

1st Department of Internal Medicine, Medical Oncology and Gastroenterology, IRCCS San Matteo and University of Pavia, Piazzale C. Golgi 2, I-27100 Pavia, Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [J] . Wen Gao, Jing He, Shi-Dai Jin, OncoTargets and therapy . 2019,第2期

机译：初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子抑制作用的抗T790M突变抗性抗性抗性抗肺癌患者的抗性抗性，抗血疱剂血管生长因子受体酪氨酸激酶激酶抑制剂
2. Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway. [J] . Nguyen KS, Kobayashi S, Costa DB Clinical lung cancer . 2009,第4期

机译：在非小细胞肺癌中，对表皮生长因子受体酪氨酸激酶抑制剂的获得性耐药取决于表皮生长因子受体途径。
3. Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors [J] . Si Sun, Hui Yu, Huijie Wang, OncoTargets and therapy . 2017,第3期

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗表皮生长因子受体突变型非小细胞肺癌患者 BIM 缺失多态性的探索性队列研究和荟萃分析

4. QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) [C] . La Ode Aman, Widisusanti Abdulkadir, Julitha Geybie Rembet, International Conference on Computation for Science and Technology . 2015

机译：喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶（EGFR-TK）抑制剂的QSAR研究

5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。

6. Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors [O] . Qi Chen, Qi Quan, Lingyu Ding, 2015

机译：表皮生长因子受体酪氨酸激酶抑制剂的继续治疗可延长对EGFR酪氨酸激酶抑制剂具有耐药性的非小细胞肺癌的疾病控制

7. >Association Of Initial Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Treatment And EGFR Exon 19 Deletion With Frequency Of The T790M Mutation In Non-Small Cell Lung Cancer Patients After Resistance To First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors [O] . Wen Gao, Jing He, Shi-Dai Jin, 2019

机译：>初始表皮生长因子受体酪氨酸激酶抑制剂治疗和EGFR外显子抑制剂的抗血液抗性抗血液肺癌患者T790M突变抗性抗性后，抗抗血疱剂患者的抗性，抗抗血管生长因子受体酪氨酸激酶抑制剂

1. 挽救性化疗治疗化疗及表皮生长因子受体酪氨酸激酶抑制剂治疗失败的晚期非小细胞肺癌的疗效和安全性 [J] . 范云 ,黄志煜 ,余海峰 . 中华肿瘤杂志 . 2010,第011期

2. 表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌的效果及对免疫功能的调节作用 [J] . 任晓辉 ,张霞 ,于剑飞 . 中国临床实用医学 . 2021,第001期

3. 表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌的效果及对免疫功能的调节作用 [J] . 任晓辉 ,张霞 ,于剑飞 . 中国临床实用医学 . 2021,第001期

4. 表皮生长因子受体酪氨酸激酶抑制剂联合甲磺酸阿帕替尼治疗晚期非小细胞肺癌的效果及安全性 [J] . 熊安对 ,潘晓青 . 河南医学研究 . 2021,第027期

5. 表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌的临床疗效及对患者免疫功能的影响 [J] . 袁军 ,夏宏伟 ,丁彦光 . 临床和实验医学杂志 . 2021,第021期

6. 扶正治癌中药组方联合表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌的临床疗效 [C] . 朱伟嵘 ,项轶 ,高蓓莉 . 中国民族医药学会肺病分会第三届学术交流年会、上海市中西医结合学会呼吸病专业委员会学术交流年会、上海市中医药学会呼吸病分会换届及学术交流年会 . 2017

7. 多西他赛与表皮生长因子受体酪氨酸激酶抑制剂二线治疗晚期非小细胞肺癌的临床观察 [A] . 张琴 . 2015

1. 用于治疗非小细胞肺癌的治疗方法和组合物 [P] . 中国专利： CN108289922B . 2022.02.08

2. 用于治疗非小细胞肺癌的治疗方法和组合物 [P] . 中国专利： CN108289922A . 2018-07-17

3. METHODS OF INHIBITION OF TYROSINE KINASE ACTIVITY IN EPIDERMAL GROWTH FACTOR RECEPTORS, BICYCLIC PYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY INHIBITING ACTIVITY OF TYROSINE KINASE IN EPIDERMAL GROWTH FACTOR RECEPTORS AND COMPOSITION ELICITING CONTRACEPTIVE EFFECT [P] . 外国专利： RU2174980C2 . 2001-10-20

机译：抑制表皮生长因子受体，双环嘧啶衍生物，药物成分显示活性抑制酪氨酸激酶活性的方法在表皮生长因子受体和成分中抑制酪氨酸激酶活性

4. methods to determine the effectiveness of a selective treatment of epidermal growth factor receptor in a patient, to treat a patient and to select a compound that inhibits the catalytically kinase activity of a variant epidermal growth factor receptor, probe, kit, compound that inhibits the catalytically kinase activity of a variant epidermal growth factor receptor, pharmaceutical composition, nucleic acid and isolated protein [P] . 外国专利： BRPI0508286A . 2007-07-31

机译：确定选择性治疗患者中表皮生长因子受体的有效性，治疗患者并选择抑制变体表皮生长因子受体的催化激酶活性的化合物的方法，探针，试剂盒，抑制催化作用的化合物表皮生长因子受体变体的激酶活性，药物组合物，核酸和分离的蛋白质

5. METHOD FOR TREATING EPIDERMAL GROWTH FACTOR RECEPTOR-DRIVEN CANCERS WITH PROTEIN KINASE C INHIBITORS IN COMBINATION WITH AN EGFR-TYROSINE KINASE INHIBITOR [P] . 外国专利： WO2020198469A1 . 2020-10-01

机译：结合蛋白酪氨酸激酶抑制剂和蛋白激酶C抑制剂治疗表皮生长因子受体驱动的癌症的方法

相关主题

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues

著录项

引文网络

相似文献

相关主题

期刊订阅